Vaccine and Clinical Trials

Vaccine efficiency and well-being

Antibody adequacy refers to the ability of vaccinations to provide the suggested beneficial outcomes for vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of a successful vaccination, such as improved health and prosperity and protection against disease and its effects on the body, mind, and finances, must be balanced against the risk of an adverse event after vaccination (AEFI). The possibility of an adverse or unwanted outcome occurring, as well as the severity of the ensuing harm to the health of those who have been vaccinated in a described population after receiving an immunization under ideal conditions of use, are known as antibody-related hazards.